Thema: US09075V1026
BioNTech SE, US09075V1026
stock-exchange-2648118_1920.jpg - Foto: THN
BioNTech stock trades at EUR 78.55 in Friday evening session
BioNTech stock enters the weekend before the company's scheduled third-quarter results. BioNTech plans to publish the figures on November 3.
ad-hoc-news.de, heute 19:49 Uhr
BioNTech SE, US09075V1026
UBS keeps USD 135 target for BioNTech stock as results near ...
BioNTech reports results on November 3, 2026. BioNTech stock costs EUR 77.80 on October 27, 2026, 0.38 percent below the Xetra close.
ad-hoc-news.de, 27.10.26 22:43 Uhr
BioNTech SE, US09075V1026
Canaccord keeps USD 132 target for BioNTech stock
BioNTech reports results on November 3, 2026. BioNTech stock costs EUR 78.65 on October 24, 2026, 0.19 percent below Xetra close.
ad-hoc-news.de, 24.10.26 20:40 Uhr
BioNTech SE, US09075V1026
BofA cuts BioNTech stock target from USD 122.00 to USD 114.00 ...
Revenue fell 60.00 percent to EUR 105.60 million for quarter ended June 30. BioNTech stock cost EUR 80.08 at Lang & Schwarz on October 20, 2026.
ad-hoc-news.de, 20.10.26 18:46 Uhr
BioNTech SE, US09075V1026
BioNTech schedules November 3 results. BioNTech stock sits ...
Second-quarter revenue fell to USD 122.31 million in 2026. BioNTech stock was EUR 77.95 on October 16, 2026 at 9:57 p.m. CEST.
ad-hoc-news.de, 17.10.26 19:36 Uhr
BioNTech SE, US09075V1026
Canaccord cuts target for BioNTech stock to USD 132.00
BMO kept a Hold rating and USD 105.00 target on October 12, 2026. BioNTech stock costs EUR 80.65, 19.91 percent below its high.
ad-hoc-news.de, 15.10.26 19:04 Uhr
BioNTech SE, US09075V1026
Morgan Stanley cuts target for BioNTech stock to USD 114.00 ...
Second-quarter revenue fell to EUR 105.60 million from EUR 260.80 million. BioNTech stock costs EUR 84.33 on October 8, 2026 after EUR 85.03.
ad-hoc-news.de, 08.10.26 11:41 Uhr
BioNTech SE, US09075V1026
BioNTech stock fell 1.96 percent despite a Buy consensus ...
BioNTech stock traded at USD 95.73 on October 6 2026 while a 20-analyst consensus set an average target of USD 115.67. Second-quarter revenue fell 59.5 percent year over year. ...
ad-hoc-news.de, 07.10.26 00:08 Uhr
BioNTech SE, US09075V1026
Morgan Stanley sets a Buy rating for BioNTech stock
Morgan Stanley's call carries a USD 115.00 target dated October 5, 2026. BioNTech stock trades at EUR 88.08 on October 6, 2026 versus EUR 86.98.
ad-hoc-news.de, 06.10.26 13:58 Uhr
BioNTech SE, US09075V1026
BioNTech stock pre-market at EUR 87.48: plus 0.57 percent ...
